chartexchange

AGEN
Agenus Inc.
stockNASDAQ

Market OpenNov 16, 2026 10:23:03 AM EST
6.50USD-3.418%(-0.23)104,918
5.3800Bid7.2800Ask1.9000Spread
Loading…
Loading…
293.65M
Healthcare
Biotechnology
CEO
Garo Armen
HQ
Lexington, MA, USA
Previous Close
$6.72
Beta
1.51
52-Week High
$10.31 2026-09-30
52-Week Low
$2.71 2026-02-05
SMA 50
$7.37
SMA 200
$5.11
Avg. Vol 10D
695,992
Avg. Vol 30D
793,146
Avg. Vol 90D
3.24M
Relative Vol
0.13
39.99M
0.5800%
1,500,000
995
Apr 12, 2024 · 1-for-20 (reverse)
AGEN Profile

agenus is an immunology company discovering and developing novel checkpoint modulators, vaccines and adjuvants to treat cancer and other diseases. we are a dedicated group of scientists, researchers, biotechnologists, physicians, and businesspeople working together toward one goal: to discover and develop therapies that can unleash the innate power of the body's immune system to treat and potentially cure hard-to-treat cancers and other diseases. our product candidates are designed to work by educating and activating the body's immune system for a precise and potent attack on cancer. our strategy is to help unlock the potential of one of the most exciting breakthrough areas in cancer treatment in decades, and to develop single agent and combination immune-oncology therapies that can help save lives. our approaches are driven by three platform technologies, including: • our antibody platforms, including our proprietary retrocyte display™ and secant® technologies, and our antibody

AGEN Performance
PeriodPriceDateChangeBeta
1W7.152026-11-09-9.23%3.411
1M6.042026-10-16+7.45%1.845
3M7.152026-08-17-9.23%1.896
6M3.582026-05-15+81.28%1.161
1Y4.322025-11-17+50.23%1.507
2Y2.722024-11-15+138.60%—
5Y73.802021-11-16-91.21%1.738
AGEN Stock Summary

Agenus Inc. (NASDAQ:AGEN) stock price today is $6.49, and today's volume is 103,504. AGEN is down 3.566% today. The 30 day average volume is 793,146. AGEN market cap is $293.65M with 45.25M shares outstanding.